Using your Suliqua® SoloStar® 100/33
Your Suliqua® SoloStar® 100/33 pen will help deliver the right dose of Suliqua for you. It is simple to use and you will quickly get to grips with how to use it and store it correctly.
How to use your Suliqua 100/33
Watch this video to learn how to use your Suliqua 100/33 pen. The animation takes you through how to prepare, use and store your Suliqua pen.
Your blood glucose diary
A blood glucose diary helps you monitor your blood glucose levels and take control of your diabetes.
Monitoring your blood glucose levels will allow you to make adjustments to your treatments once a week, whilst at home. Your dose can be adjusted according to a target set by your doctor or nurse, and will help you keep your blood glucose levels on target.
Download this digital monitoring diary and fill it in either digitally or manually after printing. Share it with your diabetes nurse or doctor each time you visit.Download
Starting on Suliqua?
The Patient Starting Guide provides information on how to store, prepare and use your new pen. It is a step by step guide that you can print off or follow on screen.Download
Your Suliqua 100/33 Passport
There may be occasions when it’s important for others to know which insulin you are taking.
This passport card is an easy way of ensuring that this information is available to you and others if needed. Download, print and fill in this Insulin passport. You can store it in your wallet or purse so it’s with you anywhere you go.Passport
Living well with Type 2 Diabetes
Understanding your condition is pivotal to living your best life with diabetes.
Download this booklet if you’d like to understand your diabetes better. It gives you clear information about type 2 diabetes, as well as what to be mindful of to ensure you keep yourself well and your diabetes well managed.Ink Saving Version Original Version
Adverse events should be reported
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to the Sanofi drug safety department on 0800 0902 314.
Alternatively, send via email to UKfirstname.lastname@example.org
▾ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
Date of preparation: June 2021